Cargando…

Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study

OBJECTIVE: Prostate cancer (PC) is the most common non-cutaneous malignancy in men worldwide. Accurate predicting the survival of elderly PC patients can help reduce mortality in patients. We aimed to construct nomograms to predict cancer-specific survival (CSS) and overall survival (OS) in elderly...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhaoxia, Zhanghuang, Chenghao, Wang, Jinkui, Tian, Xiaomao, Wu, Xin, Li, Maoxian, Mi, Tao, Liu, Jiayan, Jin, Liming, Li, Mujie, He, Dawei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259789/
https://www.ncbi.nlm.nih.gov/pubmed/35814387
http://dx.doi.org/10.3389/fonc.2022.918780
_version_ 1784741861531844608
author Zhang, Zhaoxia
Zhanghuang, Chenghao
Wang, Jinkui
Tian, Xiaomao
Wu, Xin
Li, Maoxian
Mi, Tao
Liu, Jiayan
Jin, Liming
Li, Mujie
He, Dawei
author_facet Zhang, Zhaoxia
Zhanghuang, Chenghao
Wang, Jinkui
Tian, Xiaomao
Wu, Xin
Li, Maoxian
Mi, Tao
Liu, Jiayan
Jin, Liming
Li, Mujie
He, Dawei
author_sort Zhang, Zhaoxia
collection PubMed
description OBJECTIVE: Prostate cancer (PC) is the most common non-cutaneous malignancy in men worldwide. Accurate predicting the survival of elderly PC patients can help reduce mortality in patients. We aimed to construct nomograms to predict cancer-specific survival (CSS) and overall survival (OS) in elderly PC patients. METHODS: Information on PC patients aged 65 years and older was downloaded from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox regression models were used to determine independent risk factors for PC patients. Nomograms were developed to predict the CSS and OS of elderly PC patients based on a multivariate Cox regression model. The accuracy and discrimination of the prediction model were tested by the consistency index (C-index), the area under the subject operating characteristic curve (AUC), and the calibration curve. Decision curve analysis (DCA) was used to test the clinical value of the nomograms compared with the TNM staging system and D’Amico risk stratification system. RESULTS: 135183 elderly PC patients in 2010-2018 were included. All patients were randomly assigned to the training set (N=94764) and the validation set (N=40419). Univariate and multivariate Cox regression model analysis revealed that age, race, marriage, histological grade, TNM stage, surgery, chemotherapy, radiotherapy, biopsy Gleason score (GS), and prostate-specific antigen (PSA) were independent risk factors for predicting CSS and OS in elderly patients with PC. The C-index of the training set and the validation set for predicting CSS was 0.883(95%CI:0.877-0.889) and 0.887(95%CI:0.877-0.897), respectively. The C-index of the training set and the validation set for predicting OS was 0.77(95%CI:0.766-0.774)and 0.767(95%CI:0.759-0.775), respectively. It showed that the proposed model has excellent discriminative ability. The AUC and the calibration curves also showed good accuracy and discriminability. The DCA showed that the nomograms for CSS and OS have good clinical potential value. CONCLUSIONS: We developed new nomograms to predict CSS and OS in elderly PC patients. The models have been internally validated with good accuracy and reliability and can help doctors and patients to make better clinical decisions.
format Online
Article
Text
id pubmed-9259789
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92597892022-07-08 Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study Zhang, Zhaoxia Zhanghuang, Chenghao Wang, Jinkui Tian, Xiaomao Wu, Xin Li, Maoxian Mi, Tao Liu, Jiayan Jin, Liming Li, Mujie He, Dawei Front Oncol Oncology OBJECTIVE: Prostate cancer (PC) is the most common non-cutaneous malignancy in men worldwide. Accurate predicting the survival of elderly PC patients can help reduce mortality in patients. We aimed to construct nomograms to predict cancer-specific survival (CSS) and overall survival (OS) in elderly PC patients. METHODS: Information on PC patients aged 65 years and older was downloaded from the Surveillance, Epidemiology, and End Results (SEER) database. Univariate and multivariate Cox regression models were used to determine independent risk factors for PC patients. Nomograms were developed to predict the CSS and OS of elderly PC patients based on a multivariate Cox regression model. The accuracy and discrimination of the prediction model were tested by the consistency index (C-index), the area under the subject operating characteristic curve (AUC), and the calibration curve. Decision curve analysis (DCA) was used to test the clinical value of the nomograms compared with the TNM staging system and D’Amico risk stratification system. RESULTS: 135183 elderly PC patients in 2010-2018 were included. All patients were randomly assigned to the training set (N=94764) and the validation set (N=40419). Univariate and multivariate Cox regression model analysis revealed that age, race, marriage, histological grade, TNM stage, surgery, chemotherapy, radiotherapy, biopsy Gleason score (GS), and prostate-specific antigen (PSA) were independent risk factors for predicting CSS and OS in elderly patients with PC. The C-index of the training set and the validation set for predicting CSS was 0.883(95%CI:0.877-0.889) and 0.887(95%CI:0.877-0.897), respectively. The C-index of the training set and the validation set for predicting OS was 0.77(95%CI:0.766-0.774)and 0.767(95%CI:0.759-0.775), respectively. It showed that the proposed model has excellent discriminative ability. The AUC and the calibration curves also showed good accuracy and discriminability. The DCA showed that the nomograms for CSS and OS have good clinical potential value. CONCLUSIONS: We developed new nomograms to predict CSS and OS in elderly PC patients. The models have been internally validated with good accuracy and reliability and can help doctors and patients to make better clinical decisions. Frontiers Media S.A. 2022-06-23 /pmc/articles/PMC9259789/ /pubmed/35814387 http://dx.doi.org/10.3389/fonc.2022.918780 Text en Copyright © 2022 Zhang, Zhanghuang, Wang, Tian, Wu, Li, Mi, Liu, Jin, Li and He https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhang, Zhaoxia
Zhanghuang, Chenghao
Wang, Jinkui
Tian, Xiaomao
Wu, Xin
Li, Maoxian
Mi, Tao
Liu, Jiayan
Jin, Liming
Li, Mujie
He, Dawei
Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
title Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
title_full Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
title_fullStr Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
title_full_unstemmed Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
title_short Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
title_sort development and validation of nomograms to predict cancer-specific survival and overall survival in elderly patients with prostate cancer: a population-based study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259789/
https://www.ncbi.nlm.nih.gov/pubmed/35814387
http://dx.doi.org/10.3389/fonc.2022.918780
work_keys_str_mv AT zhangzhaoxia developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT zhanghuangchenghao developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT wangjinkui developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT tianxiaomao developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT wuxin developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT limaoxian developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT mitao developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT liujiayan developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT jinliming developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT limujie developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy
AT hedawei developmentandvalidationofnomogramstopredictcancerspecificsurvivalandoverallsurvivalinelderlypatientswithprostatecancerapopulationbasedstudy